Neuropathology and Applied Neurobiology 43, 477-491 Ageing causes prominent neurovascular dysfunction associated with loss of astrocytic contacts and gliosis Aims: Normal neurovascular coupling, mediated by the fine interplay and communication of cells within the neurovascular unit, is critical for maintaining normal brain activity and cognitive function. This study investigated whether, with advancing age there is disruption of neurovascular coupling and specific cellular components of the neurovascular unit, and whether the effects of increasing amyloid (a key feature of Alzheimer's disease) would exacerbate these changes. Methods: Wild-type mice, in which amyloid deposition is absent, were compared to transgenic amyloid precursor protein (APP) littermates (TgSwDI) which develop age-dependent increases in amyloid. Baseline cerebral blood flow and responses to whisker stimulation were measured. Components of the neurovascular unit (astrocytes, end-feet, pericytes, microglia) were measured by immunohistochemistry. Results: Neurovascular coupling was progressively impaired with increasing age (starting at 12 months) but was not further altered in TgSwDI mice. Aged mice showed reduced vascular pericyte coverage relative to young but this was not related to neurovascular function. Aged mice displayed significant reductions in astrocytic end-feet expression of aquaporin-4 on blood vessels compared to young mice, and a prominent increase in microglial proliferation which correlated with neurovascular function. Conclusions: Strategies aimed to restore the loss of astrocytic end feet contact and reduce gliosis may improve neurovascular coupling.
Introduction
The neurovascular unit is a dynamic multicellular structure comprised of cerebral blood vessels, endothelial cells, astrocytes and end-feet contacts on vessels, pericytes, neurons and microglia. The neurovascular unit serves critical roles and is responsible for formation and maintenance of the blood-brain barrier, controlling the exchange of substances between blood and brain and immune surveillance [1] . Critically, the efficient communication between the cells within the neurovascular unit, known as neurovascular coupling, ensures that cerebral vessel diameter is finely tuned to neuronal activity to maintain cerebral perfusion and meet metabolic demands. Astrocytes, which contact synapses and also vasculature via their end-feet processes, are ideally located to mediate neurovascular coupling, facilitated by astrocytic calcium signalling and release of vasoactive substances from the end-foot terminus (for review see [2] ). Pericytes, contractile cells that ensheath capillary endothelial cells, have also been suggested to regulate blood flow in capillaries and may irreversibly constrict vessels following ischaemic insult [3] . Impairment in neurovascular coupling or inability of the vasculature to respond to neuronal energy demands could result in neuronal metabolic stress and lead to cellular dysfunction and ultimately cognitive decline.
Ageing, one of the most significant risk factors for development of dementia, has been shown to disrupt neurovascular coupling and to alter components of the neurovascular unit. Impairments in neurovascular coupling in mice have been shown to occur as early as 8 months [4] and also at 12 months [5] . In human brain, the fMRI BOLD response has been used to demonstrate progressive impairments in neurovascular coupling with increasing age [6, 7] . Neuropathological studies have also highlighted structural alterations in the neurovascular unit with increasing age, including a reduction in pericyte number, reduced capillary density and vascular basement membrane thickening [8.9] .
Amyloid, one of the key pathological hallmarks of Alzheimer's disease, has also been shown to impair neurovascular coupling. Several transgenic mouse lines that express mutant human amyloid precursor protein (TgAPP) display reduced vascular responses to neuronal activity with advancing age [10] [11] [12] , an impairment thought to be mediated by reactive oxygen species [13] and in particular by NADPH oxidase 2 [14] . Neurovascular coupling is also impaired in carriers of the APOE e4 allele [15] , a major risk factor for development of Alzheimer's disease that is thought to impair clearance of amyloid from the brain. In these individuals neurovascular dysfunction occurs prior to the onset of cognitive decline [15] , indicating the potential as a modifiable target for therapeutics. Accumulation of amyloid both in vessels and parenchyma of human brain and in animal models can occur in parallel with structural alterations in the neurovascular unit, notably alterations in vessel morphology, pericyte loss and vascular smooth muscle cell disruption [11, 16] .
Despite evidence that neurovascular coupling becomes disrupted with ageing and in Alzheimer's disease, the specific cell types that underlie these changes are still unknown. To address this, this study sought to perform a comprehensive characterization of the cells within the neurovascular unit and the extent of neurovascular coupling in TgAPP(TgSwDI) mice, which develop age-related amyloid accumulation and compare these changes in the absence of amyloid in wild-type littermate controls at different ages. Astrocytes and their end feet contacts and pericytes are reported to regulate cerebral blood flow and thus it was hypothesized that reduced pericyte and astrocytic end-feet coverage of vessels would be closely related to impaired neurovascular coupling and that these changes would be heightened in the presence of amyloid.
Methods

Animals
Male C57Bl/6J and heterozygous wild-type littermate TgSwDI mice [17] were studied at three age points: 6 months (n = 7 C57Bl/6J, n = 7 TgSwDI), 12 months (n = 7 C57Bl/6J, n = 5 TgSwDI) and 24 months (n = 7 C57Bl/6J, n = 9 TgSwDI). Unless otherwise stated, animals were group housed on a 12:12 hr light/dark cycle and had access to food and water ad libitum. All experiments were conducted in accordance with the Animals (Scientific Procedures) Act 1986 and local ethical approval at the University of Edinburgh and were performed under personal and project licenses granted by the Home Office. All data collection and analysis was performed by experimenters blind to the age and genetic status of the mice.
Magnetic resonance imaging to assess structural alterations, resting blood flow and vascular density Mice were initially anaesthetized with 5% isoflurane in 100% oxygen and then anaesthesia was maintained with approx 1.5% isofluorane. The right femoral vein was cannulated for administration of the iron oxide contrast agent ferumoxytol for use in Q-map imaging [18] as described below. Mice were then placed in an MRI compatible holder (Rapid Biomedical, Wurzburg, Germany). Rectal temperature and respiration were monitored throughout (SA Instruments Inc., NY, US) and maintained within normal physiological parameters. Structural T2-weighted, arterial spin labelling (ASL), R2 and R2* data were collected using an Agilent 7T preclinical scanner (Agilent Technologies, Yarnton, UK); equipped with a high-performance gradient insert (120 mm inner diameter, maximum gradient strength 400 mT/m) and using a 72 mm quadrature volume coil and a phased array mouse brain coil (Rapid Biomedical GmbH, Rimpar, Germany). ASL was performed using a Look-Locker FAIR single gradient echo (LLFAIRGE) sequence [19, 20] covering a 1.5 mm thick brain slice centred -1.7 mm posterior from Bregma based on coordinates from the Mouse Brain Atlas [21] . Forty gradient echoes spaced 200 ms apart were acquired after a sliceselective or global adiabatic inversion pulse for each phase encoding, resulting in a total observation time of approximately 16 min for a 64 9 64 imaging matrix. The flip angle was 20°. The first 20˚pulse occurred 3 ms after the inversion pulse. The echo time was 1.42 ms. Q-map imaging was performed based on published methods [18] . The technique allows the calculation of an index ("Q") that is sensitive to microvessel density and can be used to provide in vivo measures of microvessel number. "Q" is calculated based on the shifts in gradient echo and spin echo relaxation rates following the administration of an intravascular contrast agent, in this case the ultrasmall superparamagnetic iron oxide ferumoxytol (Takeda Pharmaceutical Company Limited, Japan). The protocol consisted of R2-and R2*-weighted scans performed before and 2 min after the intravenous injection of the iron oxide contrast agent ferumoxytol ( 
Magnetic resonance imaging analysis
Relative CBF maps were constructed from ASL data in Matlab using in-house scripts. CBF maps were analysed in ImageJ (v1.46, NIH, Bethesda, MD, USA) using cortical regions of interest selected from T1 maps acquired with the ASL sequence. Q-maps were calculated from relaxation rate shifts measured on spin echo and gradient echo experiments according to published methods [18] using Matlab and Statistical Parametric Mapping 8 software (SPM8, http://www.fil.ion.ucl.ac.uk/spm/sof tware/spm8/, Wellcome Trust Centre for Neuroimaging) and were analysed in ImageJ. Cortical and thalamic regions of interest were selected from T2-weighted structural scans.
Laser speckle imaging to assess neurovascular coupling
Following MRI, mice were anaesthetized by intraperitoneal injection with alpha-chloralose (50 mg/kg) and urethane (750 mg/kg). The left whiskers were cut to minimize extraneous stimulation and the right whiskers, to be stimulated, trimmed to 1 cm. Body temperature was monitored throughout the experiment using a rectal probe and maintained within the range of 36.5-37.5°C using a heat blanket. Mice were placed in a stereotaxic frame and ventilated via a nose cone with 100% oxygen at a rate of 150 breaths per minute. The head was fixed in place using ear and tooth bars and an incision was made over the midline. The scalp was retracted, the skull was cleaned of fur and a thin layer of ultrasound gel applied to prevent the skull drying. Stable baseline blood flow in the barrel cortex was recorded for 2 min using a laser speckle contrast imager (Moor FLPI2 Speckle Contrast Imager, Moor Instruments, UK). The barrel cortex was defined according to the mouse atlas [21] , measurements were performed on the surface of the skull at À0.82 mm posterior from Bregma and 3 mm laterally. The whiskers were then deflected back and forth for 30 s to stimulate blood flow to the barrel cortex. Blood flow was allowed to return to a stable baseline before beginning the next stimulation. Speckle contrast images were analysed using MoorFLPI-2 Review software (version 4.0). Peak response amplitude was recorded during stimulation, and this was expressed as % increase from baseline to give a measure of vascular responsiveness. Results were averaged from three stimulations.
Tissue processing
Mice were perfused with 20 mls phosphate-buffered saline, whole brains were removed and fixed in 4% paraformaldehyde for 48 h and processed for paraffin embedding. 6 lm coronal sections were collected at À1.7 mm posterior from Bregma based on the mouse atlas [21] .
Immunohistochemistry to assess neurovascular unit structure
Immunostaining was performed according to standard laboratory procedures. Sections were deparaffinized and endogenous peroxidase was quenched prior to antigen retrieval. Sections were blocked with 10% normal serum prior to incubation with primary antibodies overnight at 4°C. Biotinylated secondary antibodies were added for 1 h, followed by amplification using a Vector ABC Elite Kit (Vector Labs, UK). Finally, peroxidase activity was visualized using 3,3 0 diaminobenzadine tetrahydrochloride (DAB, Vector Labs, UK). For immunofluorescence, sections were deparaffinized prior to antigen retrieval, blocked with 10% normal serum and incubated with primary antibodies overnight at 4°C. AQP4 immunofluorescence was amplified using a biotinylated secondary. Sections were then incubated with AlexaFluor-conjugated secondary antibodies for 1 h at room temperature and counterstained with DAPI. Primary antibodies were as follows: 6E10 mouse monoclonal Covance SIG-39320, 1:10,000 DAB and 1:750 immunofluorescence; ColIV goat polyclonal Millipore AB769, 1:100; GFAP rat monoclonal Life-Tech 13-0300, 1:100; AQP4 rabbit polyclonal Millipore AB3594, 1:500; PDGFR-b goat polyclonal R&D Systems AF1042, 1:200; Iba1 rabbit polyclonal Menarini MP-290 1:1000; p47 rabbit polyclonal Millipore ABN1480 1:1000. Images of DAB stained sections were captured on an Olympus BX51 microscope (9100, Olympus UK, Southend-on-Sea, UK); immunofluorescence images were acquired using a laser scanning confocal microscope (9200, Zeiss 780, Carl Zeiss Microscopy, Cambridge, UK). Images were acquired from the barrel cortex to correspond with measurements of neurovascular coupling. Images were also acquired from the ventral posteromedial nuclei of the thalamus since this is a brain region that develops extensive microvascular amyloid accumulation in TgSwDI mice. 2-6 images per region were acquired for each animal. All images were analysed using ImageJ software (v1.46, NIH, Bethesda, MD, USA). Percentage area stained by 6E10, ColIV, Iba1 and p47 was used to calculate total amyloid load, vessel density, microglial density and p47 density respectively. GFAP-positive astrocytes were manually counted. For quantification of vascular amyloid load, vascular AQP4 coverage and vascular PDGFR-b coverage, colocalization between ColIV and either 6E10, AQP4 or PDGFR-b was calculated using Mander's coefficient.
Statistical analysis
Laser speckle imaging measures of vascular function and MRI measures of resting cerebral blood flow and vessel density were analysed by two-way ANOVA with age and genotype as the factors. The percentage area stained by 6E10, collagen IV, Iba1 and p47, as well as Mander's coefficient of colocalization between aquaporin-4, PDGFR-b and collagen IV, were compared using two-way ANOVA with age and genotype as the factors. Correlational analysis was performed using Spearman rank-order. All statistical analysis was performed using SPSS (v19, IBM Corp.) or Prism GraphPad software (v5, GraphPad Software Inc, La Jolla, USA) and with P < 0.05.
Results
TgSwDI mice exhibit parenchymal and vascular amyloid deposition which is absent in wild-type mice
To quantify the extent of amyloid deposition in the cortex of TgSwDI and wild-type mice, 6E10 immunohistochemistry was performed at 6 months and 24 months of age ( Figure 1 ). At 6 months of age, amyloid deposits were not detectable in wild-type mice. Similarly, in TgSwDI mice, extracellular deposits of amyloid were not observed but instead 6E10 staining of neurons was observed. In contrast, at 24 months, there was a marked accumulation of amyloid in the cortex of TgSwDI mice and as expected amyloid was not present in age-matched wildtype littermate controls. Overall, there was a significant effect of age and genotype (F 1 , 29 = 26.13, P < 0.0001 and F 1 , 29 = 67.32, P < 0.0001 respectively) and a significant interaction effect (F 1 , 29 = 24.95, P < 0.0001). These differences were due to a significant increase in amyloid in 24-month-old TgSwDI mice compared with 24-month wild-type mice in which amyloid was not present (P < 0.001). Previously it has been shown that vascular amyloid has a pronounced effect on neurovascular coupling [22, 23] . Thus, to determine the extent of vascular amyloid in TgSwDI mice, the colocalization of amyloid to collagen IV-labelled vessels was examined in the barrel cortex, the region in which neurovascular coupling was measured and the extent of parenchymal amyloid (i.e. amyloid outside vessels) was also determined (Figure 1 ). The coverage of vascular amyloid was found to be low albeit the extent of vascular amyloid significantly increased from 0.02% AE 0.025 to 0.06% AE 0.054 in 6-month and 24-month TgSwDI mice respectively (P < 0.05). The percentage of cortical vessels which were found to have vascular amyloid also significantly increased with age, from 1.3% AE 2.5 to 2.7% AE 2.4 for 6-month vs. 24-month-old mice respectively (P < 0.05). The extent of parenchymal amyloid was overall much higher than vascular amyloid in the TgSwDI mice at both 6 and 24 months. The percentage area of parenchymal amyloid staining significantly increased from 0.19% AE 0.11 to 3.55% AE 0.72 in 6-and 24-month TgSwDI mice respectively (P < 0.05).
In TgSwDI mice, amyloid deposition is particularly prominent in the thalamus [17] and thus the extent of thalamic amyloid deposition was assessed in this brain region in TgSwDI mice and compared to wild type (Figure S1 ). There were significant effects of age and genotype (F 1 , 29 = 294.5, P < 0.0001 and F 1 , 29 = 300.4, P < 0.0001 respectively) and a significant interaction effect (F 1 , 29 = 290.7, P < 0.0001). Amyloid deposition was significantly increased in 24-month-old TgSwDI mice compared with 24-month wild-type mice (P < 0.001), whereas there was no significant difference at 6 months of age (P > 0.05). Consistent with the previous characterization of TgSwDI mice [17] , the extent of vascular amyloid was found to be higher in the thalamus than in the cortex. Vascular amyloid also significantly increased from 0.003% AE 0.005 to 0.65% AE 0.19 (P < 0.001) from 6 months of age to 24 months of age in TgSwDI mice. The proportion of vessels covered by amyloid also increased significantly from 0.13% AE 0.27 to 28.6% AE 5.7 for 6-month vs. 24-month-old mice respectively (P < 0.001). Again, parenchymal amyloid load was higher than vascular load in the thalamus. The percentage area of parenchymal amyloid significantly increased from 0.1% AE 0.2 to 9.4% AE 2.8 between 6 and 24 months (P < 0.001).
Cortical resting cerebral blood flow is unchanged in wild-type and TgSwDI mice
To investigate whether ageing or amyloid deposition might affect baseline blood flow, arterial spin labelling was used to compare resting cerebral blood flow (rCBF) between groups. No significant differences in cortical blood flow were detected relative to 6-month wild-type mice (P > 0.05) (Figure 2 ). In the thalamus there were no significant effects of age or genotype, however, there was a significant interaction effect (F 1 , 29 = 5.43, P < 0.05) ( Figure S2 ).
Cortical vascular density is unchanged in wild-type and TgSwDI mice
To determine if ageing or amyloid deposition would induce alterations in cerebral blood vessels, vascular The proportion of vessels containing vascular amyloid was increased with age in TgSwDI mice. Mean AESEM n = 7-9 per group. *P < 0.05 ***P < 0.001 Scale bar = 100 lm, 20 lm. [Colour figure can be viewed at wileyonlinelibrary.com] density was assessed using both in vivo MRI and ex vivo immunohistochemical techniques. Q-map imaging was used to measure perfused vessel density in vivo, and collagen IV immunohistochemistry was used to measure vessel density in tissue slices. No significant differences in cortical vascular density were observed between groups with either Q-map imaging (P > 0.05) or immunohistochemical measures (P > 0.05) (Figure 3) .
In the thalamus, collagen IV immunohistochemistry analysis revealed significant effects of age and genotype (F 1 , 29 = 4.41, P < 0.05 and F 1 , 29 = 7.91, P < 0.01 respectively) ( Figure S3 ), however, no differences in vessel density were detected using in vivo Q-map imaging (P > 0.05).
CBF increases to whisker stimulation are significantly attenuated in aged wild-type and TgSwDI mice Laser speckle imaging was used to measure the vasodilatory response to whisker stimulation in the barrel cortex. Neurovascular coupling was significantly reduced in aged wild-type and TgSwDI mice relative to young (Figure 4 ). We detected a significant effect of age (F 2,38 = 14.31, P < 0.001), however, there was no significant effect of genotype (P > 0.05). Post hoc tests indicated that neurovascular coupling was significantly reduced in 12-and 24-month-old mice relative to 6-month mice (P < 0.001 and P < 0.001 respectively).
Reduced pericyte coverage of cortical blood vessels in aged mice
Pericytes have been suggested to regulate cortical blood flow in capillaries [3] , therefore we sought to determine whether changes in vascular pericyte coverage may underlie age-related reductions in neurovascular coupling. The extent to which cortical blood vessels are contacted by pericyte processes was assessed using colocalization analysis of PDGFR-b, as a marker of pericytes, with collagen IV-labelled vessels. As predicted, aged mice displayed significantly reduced vascular pericyte coverage compared to young mice (F 1 , 29 = 10.21, P < 0.01) but there were no significant genotype or interaction effects ( Figure 5 ). Furthermore, vascular pericyte coverage was unrelated to the extent of neurovascular coupling (r = 0.28; P > 0.05).
In the thalamus, vascular pericyte coverage analysis revealed a significant age effect (F 1 , 29 = 13.05, P < 0.01) with aged mice displaying reduced vascular pericyte coverage compared to young, but there was no effect of genotype ( Figure S4 ).
Reduced coverage of cortical blood vessels by astrocytic end-feet AQP4 in aged mice Neurovascular coupling is suggested to be mediated, in part, by contact between astrocytic end-feet and cerebral blood vessels [2] . To investigate whether alterations in astrocytic end-feet structure might underlie impairments in vascular function, the integrity of this contact was assessed using AQP4 as a marker of astrocytic end-feet and the extent co-localized to vessels determined. Significant effects of age and genotype were detected, with aged mice displaying a significant reduction in astrocytic end-feet expression of AQP4 on blood vessels compared to young mice (F 1 , 29 = 27.85, P < 0.0001), and greater vascular AQP4 coverage in TgSwDI compared to wild-type mice (F 1 , 29 = 13.41, P < 0.01) ( Figure 6 ). Interestingly, there was a significant positive correlation between neurovascular coupling and AQP4 localization on cortical blood vessels (r = 0.45, P < 0.01). There was a trend toward an increase in parenchymal expression of AQP4 in aged transgenic mice, however, this did not reach statistical significance (F 1 , 29 = 4.2, P > 0.05) (data not shown). Having identified alterations in the contact between astrocytes and blood vessels, we also sought to determine if the number of GFAP+ve astrocytes was altered with age or amyloid deposition. Analysis of GFAP-positive astrocytes revealed significant effects of age and genotype (F 1 , 29 = 36.78, P < 0.0001 and F 1 , 29 = 27.14, P < 0.0001 respectively) and also a significant interaction effect (F 1 , 29 = 28.27, P < 0.0001) ( Figure 7 ). Aged TgSwDI mice had a significantly greater number of GFAP+ve astrocytes compared to aged wild-type mice (P < 0.001).
The reduction with age in astrocytic end-feet expression of AQP4 on blood vessels was also found in the thalamus (F 1 , 29 = 33.78, P < 0.0001), however, there was no genotype effect ( Figure S5 ). In addition, a more pronounced increase in parenchymal AQP4 expression in TgSwDI mice was noted. Analysis of parenchymal AQP4 expression revealed significant effects of age and genotype (F 1 , 29 = 78.24, P < 0.0001 and F 1 , 29 = 27.81, P < 0.0001 respectively) as well as a significant interaction effect (F 1 , 29 = 45.07, P < 0.0001), whereby aged TgSwDI mice displayed a significant increase in parenchymal AQP4 compared to aged wildtype mice (P < 0.001). Similar to cortical measures, there were significant effects of age and genotype on number of GFAP+ve astrocytes in the thalamus (F 1 , 29 = 339.8, P < 0.0001 and F 1 , 29 = 184.2, P < 0.0001 respectively) and also a significant interaction effect (F 1 , 29 = 168.6, P < 0.0001) ( Figure S6 ). Aged TgSwDI mice had significantly more GFAP-positive astrocytes compared to aged wild-type mice (P < 0.001). 
Microglia density is increased with ageing and exacerbated in TgSwDI mice
Following on from the demonstration that alterations in GFAP+ve astrocytes are associated with reduced vascular function, we sought to identify whether alterations in microglia may also be related to changes in neurovascular coupling. Quantification of the density of Iba1-positive microglia was performed in the barrel cortex in adjacent sections to those used to identify astrocytic end feet processes. Significant effects of age and genotype were detected, with significantly greater Iba1 staining in aged mice compared to young (F 1 , 29 = 17.97, P < 0.001), and in TgSwDI mice compared to wild type (F 1 , 29 = 13.88, P < 0.001) (Figure 8 ). Post hoc tests revealed significantly greater Iba1 staining in aged TgSwDI compared to aged wild type (P < 0.01). Furthermore, the extent of Iba1 + ve staining correlated significantly with the extent of neurovascular coupling (r = À0.55, P < 0.01).
In the thalamus, quantification of Iba1-positive microglia revealed significant effects of age and genotype (F 1 , 29 = 133.9, P < 0.0001 and F 1 , 29 = 82.57, P < 0.0001 respectively) and also a significant interaction effect (F 1 , 29 = 48.09, P < 0.0001) ( Figure S7 ). Iba-1 + ve microglia density was also significantly increased in aged TgSwDI mice compared to aged wildtype mice (P < 0.001).
p47 subunit of NADPH oxidase 2 is increased with ageing
To further probe the mechanisms by which age may contribute to impaired neurovascular coupling we quantified immunostaining for p47, a subunit of the NADPH oxidase 2 (NOX2). This is a major contributor to reactive oxygen species, is highly expressed by glia [24] and has been shown to become highly activated in response to amyloid [14] . In the cortex, there was a significant increase in NOX2 with age (F 1 , 29 = 6.91, P < 0.05) but no effect of genotype and no interaction (Figure 9 ). Further there was no significant association between the extent of p47 staining and neurovascular coupling.
In the thalamus, there were significant effects of age and genotype (F 1 , 29 = 39.71, P < 0.001 and F 1 , 29 = 19.4, P < 0.001) respectively) and also a significant interaction effect (F 1 , 29 = 12.7, P < 0.01) (Figure S8 ). Aged TgSwDI mice had significantly increased p47 expression compared to aged wild-type mice (P < 0.001) consistent with more pronounced amyloid deposition in this brain region.
Discussion
This study demonstrates that neurovascular coupling, in the cortex, is progressively impaired with advancing age and that these changes are closely related to disruption of astrocytic end-foot expression of AQP4 on vessels and increased gliosis. There was no further impact on these changes detected in the presence of cortical amyloid. Similar to previous work [5] , age-related impairments in neurovascular coupling in wild-type mice were apparent at 12 months of age and further impaired at 24 months of age. Clinical imaging studies have also demonstrated that vascular responsiveness is reduced with increasing age [6, 7] . Impaired neurovascular coupling was not accompanied by changes in resting cortical blood flow or cortical vessel density, findings similar to those reported by Park et al. [11] . Other studies have reported reductions in baseline CBF with advancing age in human [25] and in TgAPP mice [26] using similar in vivo ASL imaging approaches. The differences between studies are not clear but baseline CBF can be influenced by anaesthetic, e.g. isoflurane used in this study is a known vasodilator. Nonetheless, in the same mice in which baseline CBF was unaltered, neurovascular coupling was profoundly impaired which is a consistent feature of several studies [4, 5, 11] . Matching neuronal activity to changes in blood flow via neurovascular coupling is essential to preserve neuronal function. Reduced vascular function is associated with cognitive impairment and conversion from MCI to Alzheimer's disease [27, 28] and thus improving or preserving neurovascular coupling could be an effective intervention.
Although our data demonstrated prominent agerelated impairments in 12-and 24-month-old mice, despite the presence of cortical amyloid deposition in TgSwDI these mice were no more impaired on measures of neurovascular coupling than their wild-type littermates. This was an unexpected finding since the presence of amyloid has been shown to impair vascular function in human brain [29] and in TgAPP mice [10, 30, 31] . Using the same TgSwDI line, Park et al. [11] demonstrated blunted responses to whisker stimulation at 3 months of age, prior to the accumulation of amyloid deposition. The authors attribute this impairment to the presence of soluble amyloid, although this is not measured directly. Differences in experimental design may also influence the outcome measures between studies. We used laser speckle imaging to measure CBF perfusion using a physiologically intact preparation that does not require a cranial window and removal of the dura over the cortex [11] . More recently, Kimbrough et al. [23] used in vivo multiphoton imaging to elegantly demonstrate that in TgAPPJ20 mice, neurovascular function was only impaired where there was evidence of vascular amyloid deposition. Within the same vessel, segments in which there was an absence of vascular amyloid displayed vascular responses that were comparable to wild-type mice. Therefore, although neurovascular coupling was not further impaired in TgSwDI mice in this study, the methods used may not have been sufficiently sensitive. In addition, other TgAPP models, such as J20 and APP23, with a greater burden of cortical vascular amyloid may exhibit greater neurovascular impairments relative to controls. It is also important to acknowledge that mice recapitulate limited aspects of the aged human and Alzheimer's disease brain where Aged mice display significantly increased cortical p47 expression compared to young mice, however, there were no differences between wild-type and TgSwDI mice. Mean AE SEM n = 7-9 per group. *P < 0.05. Scale bar = 100 lm. [Colour figure can be viewed at wileyonlinelibrary.com] co-morbidities are present, and thus findings from models need to be interpreted on this basis.
To determine the potential mechanisms that may contribute to impairments in neurovascular coupling, alterations in components of the neurovascular unit were examined at 6 and 24 months of age, ages at which neurovascular coupling was normal and profoundly impaired, respectively. Since pericytes have been suggested to regulate cerebral blood flow, [3] , we investigated the vascular coverage of pericytes and alterations with increasing age. Notably, we found a pronounced reduction in the coverage of vessels with pericytes in aged brain as compared to young, albeit we did not find any correlation between vessel function and cortical vascular pericyte coverage. It is reported that pericyte loss may primarily affect the function of capillaries [32] . However, laser speckle imaging measures perfusion alterations across a range of vessels, including capillaries and arterioles [33] and thus specific alterations in capillaries cannot be measured. Further, neurovascular unit alterations were not assessed at 12 months, when neurovascular coupling is already impaired. Dynamic changes in the neurovascular unit could account for impairments of neurovascular function in mid-age and may be distinct from those in old age.
Astrocytes and their end-feet are also known to have critical roles in regulating cerebral blood flow [2, 32] . In 24-month-old mice there was a profound loss of vascular localization of AQP4 labelling of astrocytic endfeet contacts in the cerebral cortex and thalamus, whereas 6-month-old mice demonstrated extensive colocalization between blood vessels and AQP4. Loss of vascular AQP4 localization may indicate disruption of the contact between vessels and astrocytes in aged mice. We also observed an age-related increase in the number of GFAP+ve astrocytes, suggestive of an increase in astrocytic activation. Process retraction following activation may contribute to the disruption of astrocyte/vessel contact. Our findings are in line with those of Kress et al. [34] who previously showed agerelated reductions in vascular AQP4 expression were associated with impaired glymphatic clearance. It remains unclear from this study whether ageing causes the displacement of the entire end-foot, or alternatively causes a selective disruption in AQP4 expression while leaving end-foot/vessel contact intact. We have measured vascular and parenchymal AQP4 to assess age-related mislocalization of this protein, however, the use of an additional end-foot marker such as b-dystroglycan, or ultrastructural analysis by electron microscopy, would provide evidence of end-feet localization to clarify this distinction. Nonetheless, together, the data suggest a critical role for expression of AQP4 on cerebral vasculature to maintain normal vascular function. Notably, age-related loss of vascular AQP4 is linked to cognitive decline and dementia [35, 36] .
Increased microglial numbers and indices of neuroinflammation are also reported in the ageing brain [37] and related to amyloid [38] . Similarly, we determined an increase in cortical microglial staining in aged relative to young mice, which was exacerbated in the presence of amyloid. We were also able to show a relationship between Iba1 density and measures of neurovascular coupling. Activation of microglia increases the activity of the superoxide-generating NADPH oxidase complex [39] . In line with this, we observed an increase in expression of the p47 subunit of NADPH oxidase 2 in aged mice compared to young. Interestingly, this increase was not further exacerbated in the cortex of TgSwDI mice relative to wild type, but was increased in the thalamus, suggesting that the greater levels of amyloid in this region results in much greater activation of the NADPH oxidase complex. Reactive superoxide species and downstream products such as peroxynitrite may significantly impair the vasodilatory capacity of the cerebral blood vessels [40] [41] [42] . Direct targeting of superoxide production may shed further light on whether this contributes to impaired neurovascular function with age.
In conclusion, this study shows that advanced age leads to profound neurovascular unit dysfunction. Since this impairment was most closely associated with increased gliosis and loss of astrocytic end feet contact, strategies aimed to restore these changes may improve neurovascular function and consequently may prevent/ delay age-related cognitive decline.
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Additional Supporting Information may be found in the online version of this article at the publisher's web-site: Figure S1 . Aged TgSwDI mice develop extensive thalamic amyloid deposition. (A,B) Little or no amyloid deposition is detectable in 6-month TgSwDI mice, however, amyloid is significantly increased in 24-month TgSwDI mice compared to 24-month wild-type mice. (C,D) Vascular amyloid is significantly increased in 24-month TgSwDI mice compared to 6-month mice. Mean AE SEM n = 7-9 per group. Scale bar = 100 lm, 20 lm. ***P < 0.001. Figure S2 . Alterations in thalamic resting cerebral blood flow. (A) Representative ASL maps of cerebral blood flow. (B) There was no significant effect of age or genotype on thalamic rCBF. Mean AE SEM n = 7-9 per group. Abbreviations: rCBF, resting cerebral blood flow. Figure S3 . Thalamic vessel density is increased with age and in TgSwDI mice. Vessel density was measured using two independent techniques. (A,C) Collagen immunohistochemistry detected a significant increase in thalamic vessel density in aged mice compared to young, and in TgSwDI mice compared to wild type. (B, D) In vivo Q-map imaging did not detect a difference in thalamic vessel density between groups. Mean AE SEM n = 7-9 per group. Scale bar = 100 lm *P < 0.05 **P < 0.01. to young mice, however, there were no differences between genotype at either age. Mean AE SEM n = 7-9 per group. Scale bar = 50 lm, 20 lm. **P < 0.01. Figure S5 . AQP4 expression on blood vessels is significantly reduced in aged mice compared to young. (A) Representative thalamic images of aquaporin-4 (AQP4) (green) and collagen IV (red). (B) Vascular coverage by AQP4 was assessed using Mander's coefficient. Aged mice have significantly reduced expression of AQP4 on thalamic blood vessels compared to young mice. (C) Parenchymal AQP4 expression is increased in aged TgSwDI mice. Mean AE SEM n = 7-9 per group. Scale bar = 20 lm. ***P < 0.0001. Figure S6 . GFAP+ve astrocytes are increased in aged mice and exacerbated in TgSwDI. (A) Representative images of thalamic GFAP+ve astrocytes. (B) Astrocytic activation was significantly increased in aged mice compared to young, and aged TgSwDI mice had significantly more astrocytes compared to aged wild-type mice. Mean AE SEM n = 7-9 per group. ***P < 0.001. Scale bar = 20 lm. Figure S7 . Microglial activation is enhanced in aged mice and exacerbated in TgSwDI. (A) Representative images of thalamic Iba+ve microglia. (B) Percentage area of Iba1 was significantly increased in aged mice compared to young, and further increased in aged TgSwDI compared to aged wild-type mice. Mean AE SEM n = 7-9 per group. **P < 0.01 ***P < 0.001. Scale bar = 20 lm. Figure S8 . Thalamic p47 expression is increased in aged mice and exacerbated in TgSwDI. compared to young, and further increased in aged TgSwDI compared to aged wild-type mice. (A) Representative images of thalamic p47 staining. (B) Aged mice display significantly increased thalamic p47 expression compared to young mice, and this is further increased in aged TgSwDI. Mean AE SEM n = 7-9 per group. ***P < 0.001. Scale bar = 100 lm.
